Search - tctmd.com

Displaying 741 - 760 of 1172

Sort: Relevancy | Date

Presentation TCT 2017

Infective Endocarditis after TAVR: Incidence and Clinical Management Decisions

Presenter: Bernard Prendergast, Brian K. Whisenant

November 01, 2017

Presentation TCT 2017

TCT 40: Outcome Of Patients Undergoing Trans-Catheter Implantation of Aortic Valve With Previous Mitral Valve Prosthesis (Optimal Study)

Presenter: Jean-Claude Laborde, Eric Van Belle, Luca Baldetti, MD

October 31, 2017

Presentation TCT 2017

TCT 39: Clinical Outcomes in SURTAVI Based on Revascularization Stratification

Presenter: Jean-Claude Laborde, Eric Van Belle, Lars Sondergaard

October 31, 2017

Presentation TCT 2017

TCT 31: Hybrid iFR-FFR Decision-Making Strategy in Coronary Revascularization of Patients With Severe Aortic Stenosis Undergoing TAVI

Presenter: Justin E. Davies, Bernard De Bruyne, Gabriele Pesarini, MD

October 31, 2017

Presentation TCT 2017

TCT 81: Hybrid Coronary Revascularization vs Percutaneous Strategies in Unprotected Left Main Stenosis: A Propensity Match Study

Presenter: David Hildick-Smith, Nicholas J. Lembo, Alberto Alberto Repossini, MD

October 31, 2017

Presentation TCT 2017

TCT 38: Self-Expanding TAVR for Treatment of Aortic Insufficiency: An Analysis of the STS/ACC TVT Registry

Presenter: Jean-Claude Laborde, Eric Van Belle, Saif Anwaruddin

October 31, 2017

Presentation TCT 2017

TCT 30: Instantaneous Wave-Free Period Variations after Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis

Presenter: Justin E. Davies, Bernard De Bruyne, Gabriele Pesarini, MD

October 31, 2017

Presentation TCT 2017

TCT 70: Influence of Microcirculatory Resistance on the Assessment of Coronary Stenosis Severity With Quantitative Flow Ratio (QFR): Results of an International Multicentre Study

Presenter: Nick Curzen, William F. Fearon, Hernan Mejia-Renteria, MD

October 31, 2017

Presentation TCT 2017

TCT 37: Sudden Cardiac Death in Patients With Severe Aortic Stenosis

Presenter: Jean-Claude Laborde, Eric Van Belle, Tomohiko Taniguchi, MD

October 31, 2017

Presentation TCT 2017

TCT 29: Mechanism of Low Fractional Flow Reserve in Lesions Without Angiographic Significant Stenosis: Role of Hidden Plaque Burden

Presenter: Justin E. Davies, Bernard De Bruyne, Jonghanne Park, MD

October 31, 2017

Presentation TCT 2017

TCT 67: Clinical Relevance of Functionally Insignificant Moderate Coronary Artery Stenosis Assessed by 3-vessel Fractional Flow Reserve Measurement

Presenter: Allen Jeremias, Amir Lerman, Jonghanne Park, MD

October 31, 2017

Presentation TCT 2017

PARTNER 2A and SAPIEN 3 Cost-effectiveness: Cost-effectiveness of TAVR vs SAVR in Intermediate-Risk Patients With Aortic Stenosis

Presenter: Patrick W. Serruys, David J. Cohen

October 31, 2017

Presentation TCT 2017

Switzerland Presents: A Case of Severe Symptomatic Aortic Stenosis and Complex Coronary Artery Disease - ECMO Support?

Presenter: Hyo-Soo Kim, Quang Ngoc Nguyen, Stephane Noble

October 31, 2017

Presentation TCT 2017

Optimal Technique 1: Hemodynamic Assessment of Renal Stenosis

Presenter: Michael R. Jaff, Stephen C. Textor, Massoud A. Leesar

October 31, 2017

Presentation TCT 2017

Case #2 Introduction: 85-Year-Old Patient With Previous Stents and Severe Aortic Stenosis, Reduced LVEF, Chronic Anemia, and Mild Renal Impairment Develops Atrial Fibrillation After TAVR

Presenter: Nick Curzen, Rod H. Stables

October 31, 2017

Presentation TCT 2017

Case #1 Introduction: Low-Risk 65-Year-Old Patient With Severe Aortic Stenosis Refuses Surgical TAVR Because They Want TAVR

Presenter: Nick Curzen, Rod H. Stables

October 31, 2017

Presentation TCT 2017

When is TAVR Indicated for Low Gradient AS With Preserved Ejection Fraction? Case Examples

Presenter: Mackram F. Eleid

October 30, 2017

Presentation TCT 2017

Clinical Management of Low Flow-Low Gradient AS: The Role of TAVR

Presenter: Howard C. Herrmann

October 30, 2017

Presentation TCT 2017

Classifying Aortic Stenosis According to Pathophysiology and Hemodynamics An Echocardiographers Perspective

Presenter: Philippe Pibarot

October 30, 2017

Presentation TCT 2017

How to Optimally Perform Valve-in-Valve Implantation in a Small Surgical Valve (Including Bioprosthetic Valve Fracture) Case Examples

Presenter: Danny Dvir

October 30, 2017

Advertisement

Infective Endocarditis after TAVR: Incidence and Clinical Management Decisions

TCT 40: Outcome Of Patients Undergoing Trans-Catheter Implantation of Aortic Valve With Previous Mitral Valve Prosthesis (Optimal Study)

TCT 39: Clinical Outcomes in SURTAVI Based on Revascularization Stratification

TCT 31: Hybrid iFR-FFR Decision-Making Strategy in Coronary Revascularization of Patients With Severe Aortic Stenosis Undergoing TAVI

TCT 81: Hybrid Coronary Revascularization vs Percutaneous Strategies in Unprotected Left Main Stenosis: A Propensity Match Study

TCT 38: Self-Expanding TAVR for Treatment of Aortic Insufficiency: An Analysis of the STS/ACC TVT Registry

TCT 30: Instantaneous Wave-Free Period Variations after Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis

TCT 70: Influence of Microcirculatory Resistance on the Assessment of Coronary Stenosis Severity With Quantitative Flow Ratio (QFR): Results of an International Multicentre Study

TCT 37: Sudden Cardiac Death in Patients With Severe Aortic Stenosis

TCT 29: Mechanism of Low Fractional Flow Reserve in Lesions Without Angiographic Significant Stenosis: Role of Hidden Plaque Burden

TCT 67: Clinical Relevance of Functionally Insignificant Moderate Coronary Artery Stenosis Assessed by 3-vessel Fractional Flow Reserve Measurement

PARTNER 2A and SAPIEN 3 Cost-effectiveness: Cost-effectiveness of TAVR vs SAVR in Intermediate-Risk Patients With Aortic Stenosis

Switzerland Presents: A Case of Severe Symptomatic Aortic Stenosis and Complex Coronary Artery Disease - ECMO Support?

Optimal Technique 1: Hemodynamic Assessment of Renal Stenosis

Case #2 Introduction: 85-Year-Old Patient With Previous Stents and Severe Aortic Stenosis, Reduced LVEF, Chronic Anemia, and Mild Renal Impairment Develops Atrial Fibrillation After TAVR

Case #1 Introduction: Low-Risk 65-Year-Old Patient With Severe Aortic Stenosis Refuses Surgical TAVR Because They Want TAVR

When is TAVR Indicated for Low Gradient AS With Preserved Ejection Fraction? Case Examples

Clinical Management of Low Flow-Low Gradient AS: The Role of TAVR

Classifying Aortic Stenosis According to Pathophysiology and Hemodynamics An Echocardiographers Perspective

How to Optimally Perform Valve-in-Valve Implantation in a Small Surgical Valve (Including Bioprosthetic Valve Fracture) Case Examples

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content